<?xml version="1.0" encoding="UTF-8"?>
<ref id="B264-pharmaceuticals-14-00381">
 <label>264.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Liu</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Shen</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Lan</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Jiang</surname>
    <given-names>Q.</given-names>
   </name>
   <name>
    <surname>Xie</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Huang</surname>
    <given-names>H.</given-names>
   </name>
  </person-group>
  <article-title>Effects of berberine on matrix accumulation and NF-kappa B signal pathway in alloxan-induced diabetic mice with renal injury</article-title>
  <source>Eur. J. Pharmacol.</source>
  <year>2010</year>
  <volume>638</volume>
  <fpage>150</fpage>
  <lpage>155</lpage>
  <pub-id pub-id-type="doi">10.1016/j.ejphar.2010.04.033</pub-id>
  <pub-id pub-id-type="pmid">20447389</pub-id>
 </element-citation>
</ref>
